Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
dl-2-(difluoromethyl) ornithine (1 trial)
ex vivo activated immune cells (1 trial)
abciximab (Reopro) (1 trial)
Trials (3 total)
Trial APIs (3 total)